Adjarai, Al-furqan .

HRN: 26-69-21  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
CEFUROXIME 750MG (VIAL)
06/23/2026
06/29/2026
IV
230mg
Q8
Acute Bacterial Infection
Checking Initial Appropriateness 
06/26/2026
CEFTRIAXONE 1G (VIAL)
06/26/2026
07/02/2026
IV
690mg
OD
UTI
Checking Initial Appropriateness 
06/27/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/27/2026
07/04/2026
IV
690mg
Q6h
Uti
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: